Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

Common arthritis drug also lowers blood pressure

Scientists have known for a while that methotrexate helps with inflammation, but it may also help...

AI enables precise gene editing

A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...

Shingles vaccine may reduce risk of heart attack and stroke 

Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...

Content from other channels on our network

New food safety regulator for Victoria

Discovery improves flavour of Chinese spirits

Hyperspectral imaging for food grading

Walkers Chocolates introduces recyclable paper wrapper

Australians back egg industry amid biosecurity concerns

Lagoon cover dewatering solution for Gippsland Water

Large-scale battery boom points to a cheaper power alternative

Samsara Eco opens first circular plastics plant

Recycling program overdue for household appliances

Tyre recycling project addresses mining industry waste

Tas doctors "strongly oppose" any taxpayer-funded home birth scheme

Perich Centre for Robotics & Health Technology opens in Liverpool

Australia will soon have its own 'centre for disease control'. Let's not repeat the chaos of the US

Report: Sepsis more prevalent, deadly and costly than previously understood

Patient-centric digital pathway seeks to transform short-stay surgery